March 6, 2026
Two Johnson & Johnson units have agreed to pay $65 million to settle a proposed antitrust class action by health plans and others claiming they were overcharged for the pulmonary hypertension drug Tracleer.
. . .
Sharon Robertson, a lead attorney for the plaintiffs, said the settlement will provide “meaningful relief” for the class of so-called third-party payors that purchased Tracleer and its generic version over the span of nearly a decade.
. . .
For plaintiffs: Sharon Robertson of Cohen Milstein Sellers & Toll; and Thomas Sobol of Hagens Berman Sobol Shapiro
Read Johnson & Johnson Units to Pay $65 Million to Settle Tracleer Antitrust Class Action.